Literature DB >> 7072155

Cold-adapted recombinants of influenza A virus in MDCK cells. I. Development and characterization of A/Ann Arbor/6/60 X A/Alaska/6/77 recombinant viruses.

T Odagiri, D C DeBorde, H F Maassab.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7072155     DOI: 10.1016/0042-6822(82)90067-8

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


× No keyword cloud information.
  10 in total

1.  Mutation in NS2, a nonstructural protein of influenza A virus, extragenically causes aberrant replication and expression of the PA gene and leads to generation of defective interfering particles.

Authors:  T Odagiri; K Tobita
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

2.  Biological characteristics of a cold-adapted influenza A virus mutation residing on a polymerase gene.

Authors:  T Odagiri; A Tosaka; N Ishida; H F Maassab
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

3.  Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines.

Authors:  M H Snyder; R F Betts; D DeBorde; E L Tierney; M L Clements; D Herrington; S D Sears; R Dolin; H F Maassab; B R Murphy
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

4.  Cold-adapted reassortants of influenza A virus: pathogenicity of A/Ann Arbor/6/60 X A/Alaska/6/77 reassortant viruses in vivo and in vitro.

Authors:  A W Heath; H F Maassab; T Odagiri; D C DeBorde; C W Potter
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

5.  Attenuation of wild-type human influenza A virus by acquisition of the PA polymerase and matrix protein genes of influenza A/Ann Arbor/6/60 cold-adapted donor virus.

Authors:  M H Snyder; M L Clements; D De Borde; H F Maassab; B R Murphy
Journal:  J Clin Microbiol       Date:  1985-11       Impact factor: 5.948

6.  Serological evaluation of an influenza A virus cold-adapted reassortant live vaccine, CR-37 (H1N1), in Japanese adult volunteers.

Authors:  N Yamane; Y Nakamura; M Yuki; T Odagiri; N Ishida
Journal:  J Hyg (Lond)       Date:  1984-04

7.  Analysis of an influenza A virus mutant with a deletion in the NS segment.

Authors:  D A Buonagurio; M Krystal; P Palese; D C DeBorde; H F Maassab
Journal:  J Virol       Date:  1984-02       Impact factor: 5.103

8.  Evaluation of cold-recombinant influenza A/Korea (CR-59) virus vaccine in infants.

Authors:  E L Anderson; R B Belshe; B Burk; J Bartram; H F Maassab
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

9.  Generation and protective efficacy of a cold-adapted attenuated avian H9N2 influenza vaccine.

Authors:  Yandi Wei; Lu Qi; Huijie Gao; Honglei Sun; Juan Pu; Yipeng Sun; Jinhua Liu
Journal:  Sci Rep       Date:  2016-07-26       Impact factor: 4.379

10.  A Mutated PB1 Residue 319 Synergizes with the PB2 N265S Mutation of the Live Attenuated Influenza Vaccine to Convey Temperature Sensitivity.

Authors:  Andrew Cox; Jordana Schmierer; Josephine D'Angelo; Andrew Smith; Dustyn Levenson; John Treanor; Baek Kim; Stephen Dewhurst
Journal:  Viruses       Date:  2020-10-31       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.